help to increase treatment engagement and
retention.^129 As is true in the general population,
evidence-based pharmaceutical interventions
should be provided to patients in the criminal
justice population along with psychosocial
therapies.^130
Individuals with addiction facing release and
reentry should be assured appropriate post-
release community-based treatment, disease
management and support services.^131